• 1321 Upland Dr. PMB 20205, Houston, Texas, 77043, US
  • Time : Monday-Friday 09am-5pm
  • Trophy Winning
  • Ceritified ( ISO 9005-2010 )
+1 210-775-2636 (USA) Quick CalL

Recombinant Proteins Market

Get a Free Sample


Recombinant Proteins Market

Recombinant Proteins Market Share, Size, Trends, Industry Analysis Report, By Product Type, By Application, By Region, Segment Forecast, 2022 – 2030

Global Recombinant Proteins Market, By Product Type (Hormone, Growth Factor, Cytokines, Enzymes, Others), By Application (Research Application, Therapeutic Use, Biotechnology Industry), and Region - COVID-19 Impact Analysis and Forecast to 2030

 

Industry Overview:

The recombinant proteins market has seen remarkable growth owing to immense potential in cancer therapy research and development. Further, Recombinant proteins require less clinical trial time as compared to small molecules, which helps enhance patient protection and provides pharmaceutical companies with longer exclusive sales time. According to World Health Organization, cancer is the second-leading cause of death, globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Owing to this, the market is likely to fuel in the coming years.

 

Key Market Drivers:
Increasing focus towards biologic products is likely to drive the market.

Key Market Restraint:
Lack of skilled professionals is likely to hinder market growth.

 

Key Players Covered:

Some of the key competitors in the Recombinant Proteins market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Novo Nordisk A/S, Eli Lilly and Company., Merck KGaA, Abcam PLC, Amgen Inc., Sanofi SA, Enzo Life Sciences, Inc others

 

Regional Analysis:

North America dominate the global recombinant proteins. Dominance of the region can be attributed to an increase in patients with cancer, diabetes, and other major chronic diseases and rising number of research and development programs and government funding.

 

Recombinant Proteins Market Report Scope

Segmentation of the Global Recombinant Proteins Market,2021 – 2028

By  Product Type
  1. Hormone
  2. Growth Factor
  3. Cytokines
  4. Enzymes
  5. Others

By   Resin Type
  1. Research Application
  2. Therapeutic Use
  3. Biotechnology Industry

By Region
  1. North America (U.S., Canada and Mexico)
  2. Europe (Germany, United Kingdom, France, Italy, Spain, Russia, Nordics, Benelux and Rest of Europe)
  3. Asia Pacific (China, India, Japan, South Korea, Oceania, and Rest of Asia Pacific)
  4. Middle East & Africa (GCC, South Africa and Rest of the Middle East & Africa)
  5. South America (Brazil, Argentina, Chile, Peru, and Rest of South America)

 

Key Market Segmentation

Global Recombinant Proteins Market- By Product Type

  1. Hormone
  2. Growth Factor
  3. Cytokines
  4. Enzymes
  5. Others

 

Global Account Software Market- By Application

  1. Research Application
  2. Therapeutic Use
  3. Biotechnology Industry

 

Global Recombinant Proteins Market- By Region

North America

  1. US
  2. Canada
  3. Mexico

 Europe

  1. Germany
  2.  UK
  3.  France
  4.  Italy
  5. Spain
  6. Russia
  7. Benelux
  8. Nordics
  9. Rest of Europe

 Asia-Pacific

  1.  China
  2.  India
  3.  Japan
  4.  South Korea
  5.  Rest of Asia-Pacific

 Middle East and Africa

 South America

1. Methodology & Scope

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

1.5. List of abbreviations

2. Assumptions

3. Research Methodology

3.1. Data Mining

3.2. Secondary Research

3.3. Primary Research

3.4. Data Sources

3.5. Data Triangulation

3.6. Bottom-up Approach

3.7. Top-Down Approach

4. Executive Summary

4.1. Market Overview

4.2. Global Recombinant Proteins Market Geographical Analysis (CAGR %)

4.3. Global Recombinant Proteins Market, By Product Type (US$ Million)

4.4. Global Recombinant Proteins Market, By Application (US$ Million)

4.5. Future Market Opportunities

4.6. Global Market Split

5. Market Dynamics

5.1. Market Drivers

5.2. Market Restraints

5.3. Opportunities Analysis

5.4. Emerging Trends Analysis

5.4.1. Demand Side Analysis

5.4.2. Supply Side Analysis

6. Key Insights

6.1. Macro and Micro Economic Indicators

6.2. Consolidated SWOT Analysis of Key Players.

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Threat of substitutes

6.3.5. Threat of rivalry

6.3.6. Market condition

6.4. PESTEL Analysis

6.5. Key Product Developments

6.6. Value Chain Analysis

6.7. Cost Structure Analysis

6.8. Price Trend Analysis

6.8.1. Weighted Average Price

6.8.2. Price Impact-COVID-19

7. Impact Analysis of COVID-19 on Global Recombinant Proteins Market

7.1. Short-Term Impact of COVID-19 on the Global Recombinant Proteins Market

7.2. Long-Term Impact of COVID-19 Global Recombinant Proteins Market

7.3. Impact of COVID-19 on the Parent Market

7.4. Sales and Financial Analysis of  Recombinant Proteins Market

8. Global Recombinant Proteins Market Analysis, Insights and Forecast, 2017-2028

8.1. Key Findings / Summary

8.2. Market Size Estimates and Forecasts

8.2.1. By Product Type (Value)

8.2.1.1. Hormone

8.2.1.2. Growth Factor

8.2.1.3. Cytokines

8.2.1.4. Enzymes

8.2.1.5. Others

8.2.2. By Application (Value)

8.2.2.1. Research Application

8.2.2.2. Therapeutic Use

8.2.2.3. Biotechnology Industry

8.2.3. By Region (Value)

8.2.3.1. North America

8.2.3.2. Europe

8.2.3.3. Asia Pacific

8.2.3.4. Middle East and Africa

8.2.3.5. South America

9. North America Recombinant Proteins Market Analysis, Insights and Forecast, 2017-2028

9.1. Market Size Estimates and Forecasts

9.1.1. By Product Type (Value)

9.1.1.1. Hormone

9.1.1.2. Growth Factor

9.1.1.3. Cytokines

9.1.1.4. Enzymes

9.1.1.5. Others

9.1.2. By Application (Value)

9.1.2.1. Research Application

9.1.2.2. Therapeutic Use

9.1.2.3. Biotechnology Industry

9.1.3. By Country (Value)

9.1.3.1. U.S.

9.1.3.2. Canada

9.1.3.3. Mexico

10. Europe Recombinant Proteins Market Analysis, Insights and Forecast, 2017-2028

10.1. Market Size Estimates and Forecasts

10.1.1. By Product Type (Value)

10.1.1.1. Hormone

10.1.1.2. Growth Factor

10.1.1.3. Cytokines

10.1.1.4. Enzymes

10.1.1.5. Others

10.1.2. By Application (Value)

10.1.2.1. Research Application

10.1.2.2. Therapeutic Use

10.1.2.3. Biotechnology Industry

10.1.3. By Country (Value)

10.1.3.1. Germany

10.1.3.2. United Kingdom

10.1.3.3. France

10.1.3.4. Italy

10.1.3.5. Spain

10.1.3.6. Russia

10.1.3.7. Benelux

10.1.3.8. Nordics

10.1.3.9. Rest of Europe

11. Asia Pacific Recombinant Proteins Market Analysis, Insights and Forecast, 2017-2028

11.1. Market Size Estimates and Forecasts

11.1.1. By Product Type (Value)

11.1.1.1. Hormone

11.1.1.2. Growth Factor

11.1.1.3. Cytokines

11.1.1.4. Enzymes

11.1.1.5. Others

11.1.2. By Application (Value)

11.1.2.1. Research Application

11.1.2.2. Therapeutic Use

11.1.2.3. Biotechnology Industry

11.1.3. By Country (Value)

11.1.3.1. China

11.1.3.2. Japan

11.1.3.3. India

11.1.3.4. Southeast Asia

11.1.3.5. Oceania

11.1.3.6. Rest of Asia Pacific

12. Middle East and Africa Recombinant Proteins Market Analysis, Insights and Forecast, 2017-2028

12.1. Market Size Estimates and Forecasts

12.1.1. By Product Type (Value)

12.1.1.1. Hormone

12.1.1.2. Growth Factor

12.1.1.3. Cytokines

12.1.1.4. Enzymes

12.1.1.5. Others

12.1.2. By Application (Value)

12.1.2.1. Research Application

12.1.2.2. Therapeutic Use

12.1.2.3. Biotechnology Industry

12.1.3. By Country (Value)

12.1.3.1. South Africa

12.1.3.2. GCC

12.1.3.3. Rest of Middle East and Africa

13. South America Recombinant Proteins Market Analysis, Insights and Forecast, 2017-2028

13.1. Market Size Estimates and Forecasts

13.1.1. By Product Type (Value)

13.1.1.1. Hormone

13.1.1.2. Growth Factor

13.1.1.3. Cytokines

13.1.1.4. Enzymes

13.1.1.5. Others

13.1.2. By Application (Value)

13.1.2.1. Research Application

13.1.2.2. Therapeutic Use

13.1.2.3. Biotechnology Industry

13.1.3. By Country (Value)

13.1.3.1. Brazil

13.1.3.2. Argentina

13.1.3.3. Chile

13.1.3.4. Peru

13.1.3.5. Rest of South America

14. Competition Matrix

14.1. Business Strategies & Insights Adopted by Leading Players

15. Global Recombinant Proteins Market Revenue Share Analysis, By Key Market Participants, 2021

16. Company Profiles

16.1. Bio-Rad Laboratories, Inc.,

16.1.1. Company Overview

16.1.2. Description

16.1.3. Product Benchmarking

16.1.4. Financials Performance (Data as available in the public domain and/or on paid databases)

16.1.5. Recent Developments

16.1.6. COVID – 19 Response

16.1.7. Strategy & Business Overview

Similar information shall be provided for all the below companies

17. Key Takeaways

18. Transcripts of the Primary Interview Respondents

Key Market Segmentation

Global Recombinant Proteins Market- By Product Type

  1. Hormone
  2. Growth Factor
  3. Cytokines
  4. Enzymes
  5. Others

 

Global Account Software Market- By Application

  1. Research Application
  2. Therapeutic Use
  3. Biotechnology Industry

 

Global Recombinant Proteins Market- By Region

North America

  1. US
  2. Canada
  3. Mexico

 Europe

  1. Germany
  2.  UK
  3.  France
  4.  Italy
  5. Spain
  6. Russia
  7. Benelux
  8. Nordics
  9. Rest of Europe

 Asia-Pacific

  1.  China
  2.  India
  3.  Japan
  4.  South Korea
  5.  Rest of Asia-Pacific

 Middle East and Africa

 South America

Frequently Asked Questions (FAQ):

report

Report ID: VBI36
----------------- Feb-2023
-----------------
Format: PDF/Excel

Choose license type
Quick contact

Get Solution

Organically grow the holistic world view of disruptive innovation via workplace diversity

Contact Us